Literature DB >> 26220367

Role of brain infarcts in behavioral variant frontotemporal dementia: Clinicopathological characterization in the National Alzheimer's Coordinating Center database.

Teresa Torralva1, Luciano A Sposato2, Patricia M Riccio3, Ezequiel Gleichgerrcht4, María Roca5, Jon B Toledo6, John Q Trojanowski6, Walter A Kukull7, Facundo Manes1, Vladimir Hachinski3.   

Abstract

Diagnosing behavioral variant frontotemporal dementia (bvFTD) in patients with prior history of stroke or with silent brain infarcts on neuroimaging studies can be challenging. Vascular changes in patients with bvFTD are not unusual, but bvFTD tends to be ruled out in the presence of cerebrovascular disease. We aimed to identify the clinical, cognitive, and risk factor profile of bvFTD with coexistent cerebrovascular disease (V-bvFTD). We compared demographic data, clinical diagnoses, vascular risk factors, functional status, and normalized neuropsychological z-scores between patients with V-bvFTD versus bvFTD without concomitant cerebrovascular disease (NV-bvFTD) from the National Alzheimer's Coordinating Centre database. We included 391 neuropathologically-diagnosed cases of frontotemporal lobe degeneration. We excluded patients that were diagnosed with aphasic variants of frontotemporal dementia before death. Patients with V-bvFTD (n = 62) were older at the time of onset of cognitive decline (71.6 vs. 62.5 years, p < 0.001) and death (78.7 vs. 69.6, p < 0.001), more likely to be hypertensive (75.8% vs. 45.7%, p = 0.002) and to have a history of stroke (21.2% vs. 6.1%, p = 0.007) than those with NV-bvFTD (n = 329). V-bvFTD was often underdiagnosed, affected elderly patients, and had a similar cognitive profile as NV-bvFTD despite the presence of brain infarcts. In the whole cohort, we observed enhanced cognitive performance with increasing age quintiles despite larger proportions of cerebrovascular disease pathology, likely meaning that frontotemporal lobe degeneration-related primary neurodegeneration exerts a stronger impact on cognition than cerebrovascular disease. Coexisting cerebrovascular disease should not preclude the diagnosis of bvFTD.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dementia; Frontotemporal; Infarct; Risk; Stroke; Vascular

Mesh:

Year:  2015        PMID: 26220367      PMCID: PMC4562890          DOI: 10.1016/j.neurobiolaging.2015.06.026

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  30 in total

1.  Trail making test, part B as a measure of executive control: validation using a set-switching paradigm.

Authors:  K Arbuthnott; J Frank
Journal:  J Clin Exp Neuropsychol       Date:  2000-08       Impact factor: 2.475

2.  Prevalence and impact of cerebrovascular lesions in Alzheimer and lewy body diseases.

Authors:  Kurt A Jellinger
Journal:  Neurodegener Dis       Date:  2010-02-18       Impact factor: 2.977

3.  Cognitive impact of subcortical vascular and Alzheimer's disease pathology.

Authors:  Helena C Chui; Chris Zarow; Wendy J Mack; William G Ellis; Ling Zheng; William J Jagust; Dan Mungas; Bruce R Reed; Joel H Kramer; Charles C Decarli; Michael W Weiner; Harry V Vinters
Journal:  Ann Neurol       Date:  2006-12       Impact factor: 10.422

4.  Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease.

Authors:  K A Jellinger; J Attems
Journal:  Acta Neuropathol       Date:  2006-11-07       Impact factor: 17.088

5.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

Review 6.  The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery.

Authors:  Sandra Weintraub; David Salmon; Nathaniel Mercaldo; Steven Ferris; Neill R Graff-Radford; Helena Chui; Jeffrey Cummings; Charles DeCarli; Norman L Foster; Douglas Galasko; Elaine Peskind; Woodrow Dietrich; Duane L Beekly; Walter A Kukull; John C Morris
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Apr-Jun       Impact factor: 2.703

7.  Determinants of survival in behavioral variant frontotemporal dementia.

Authors:  B Garcin; P Lillo; M Hornberger; O Piguet; K Dawson; P J Nestor; J R Hodges
Journal:  Neurology       Date:  2009-11-17       Impact factor: 9.910

Review 8.  Frontotemporal dementia in elderly individuals.

Authors:  Atik Baborie; Tim D Griffiths; Evelyn Jaros; Parastoo Momeni; Ian G McKeith; David J Burn; G Keir; Andrew J Larner; David M Mann; Robert Perry
Journal:  Arch Neurol       Date:  2012-08

9.  Magnetic resonance imaging signatures of tissue pathology in frontotemporal dementia.

Authors:  Jennifer L Whitwell; Keith A Josephs; Martin N Rossor; John M Stevens; Tamas Revesz; Janice L Holton; Safa Al-Sarraj; Alison K Godbolt; Nick C Fox; Jason D Warren
Journal:  Arch Neurol       Date:  2005-09

10.  Progression in frontotemporal dementia: identifying a benign behavioral variant by magnetic resonance imaging.

Authors:  Rhys R Davies; Christopher M Kipps; Joanna Mitchell; Jillian J Kril; Glenda M Halliday; John R Hodges
Journal:  Arch Neurol       Date:  2006-11
View more
  2 in total

1.  Modifiable potential risk factors in familial and sporadic frontotemporal dementia.

Authors:  Helmi Soppela; Kasper Katisko; Yasmine Gadola; Johanna Krüger; Päivi Hartikainen; Antonella Alberici; Alberto Benussi; Anne Koivisto; Annakaisa Haapasalo; Anne M Remes; Barbara Borroni; Eino Solje
Journal:  Ann Clin Transl Neurol       Date:  2022-06-29       Impact factor: 5.430

2.  Smoking and Obesity as Risk Factors in Frontotemporal Dementia and Alzheimer's Disease: The HUNT Study.

Authors:  Hege Rasmussen Eid; Tor Atle Rosness; Ole Bosnes; Øyvind Salvesen; Marlen Knutli; Eystein Stordal
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2019-01-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.